These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25196808)

  • 21. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
    Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria.
    Litvinova E; Darnige L; Kirilovsky A; Burnel Y; de Luna G; Dragon-Durey MA
    Front Immunol; 2018; 9():2971. PubMed ID: 30619328
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
    Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generation in antiphospholipid syndrome.
    Zuily S; Ait Aissa K; Membre A; Regnault V; Lecompte T; Wahl D
    Lupus; 2012 Jun; 21(7):758-60. PubMed ID: 22635224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Non-criteria" antiphospholipid antibodies add value to antiphospholipid syndrome diagnoses in a large Chinese cohort.
    Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Zhou J; Norman GL; Wang X; Yang C; Shi H
    Arthritis Res Ther; 2020 Feb; 22(1):33. PubMed ID: 32085759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of antiphospholipid-induced thrombosis: effects on the protein C system.
    Wahl D; Membre A; Perret-Guillaume C; Regnault V; Lecompte T
    Curr Rheumatol Rep; 2009 Feb; 11(1):77-81. PubMed ID: 19171115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome.
    Zhang S; Wu Z; Li P; Bai Y; Zhang F; Li Y
    Medicine (Baltimore); 2015 Nov; 94(46):e2059. PubMed ID: 26579816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated protein C resistance in antiphospholipid thrombosis syndrome.
    Wu J; Zhou Z; Li X; Li X; Chen Y; Wang G; Wang Z
    Chin Med J (Engl); 2000 Aug; 113(8):699-701. PubMed ID: 11776051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibody syndrome.
    Lim W
    Hematology Am Soc Hematol Educ Program; 2009; ():233-9. PubMed ID: 20008203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into the hypercoagulable state of high-risk thrombotic APS patients: Contribution of aβ2GPI and aPS/PT antibodies.
    Pontara E; Cattini MG; Cheng C; Bison E; Denas G; Pengo V
    J Thromb Haemost; 2021 Mar; 19(3):805-813. PubMed ID: 33249717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives.
    Foret T; Dufrost V; Lagrange J; Costa P; Mourey G; Lecompte T; Magy-Bertrand N; Regnault V; Zuily S; Wahl D
    Curr Rheumatol Rep; 2024 May; 26(5):178-187. PubMed ID: 38372872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between phenomenon of acquired activated protein C resistance and antiphospholipid antibodies in patients with systemic lupus erythematosus].
    Hu YQ; Chen FP; Xie QZ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):469-72. PubMed ID: 12536506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus.
    Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A
    Lupus; 2002; 11(11):730-5. PubMed ID: 12475003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
    Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
    Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Non-criteria antiphospholipid antibodies': bridging the gap between seropositive and seronegative antiphospholipid syndrome.
    Truglia S; Mancuso S; Capozzi A; Recalchi S; Riitano G; Longo A; De Carolis S; Spinelli FR; Alessandri C; Ceccarelli F; De Carolis C; Misasi R; Sorice M; Conti F
    Rheumatology (Oxford); 2022 Feb; 61(2):826-833. PubMed ID: 33970223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.